Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/70317
Campo DC Valoridioma
dc.contributor.authorMorales-Orue, Ignacioen_US
dc.contributor.authorZafra-Martin, Juanen_US
dc.contributor.authorGarcia, Lauraen_US
dc.contributor.authorChicas-Sett, Rodolfoen_US
dc.contributor.authorCastilla-Martinez, Juanen_US
dc.contributor.authorCabezon, Maria Auxiliadoraen_US
dc.contributor.authorBurgos, Javieren_US
dc.contributor.authorLloret Sáez-Bravo, Martaen_US
dc.contributor.authorLara, Pedro C.en_US
dc.date.accessioned2020-02-16T07:28:49Z-
dc.date.available2020-02-16T07:28:49Z-
dc.date.issued2020en_US
dc.identifier.issn2218-676Xen_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/70317-
dc.description.abstractBreast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.en_US
dc.languageengen_US
dc.relation.ispartofTranslational Cancer Researchen_US
dc.sourceTranslational Cancer Research [ISSN 2218-676X], v. 9, p. S197-S206en_US
dc.subject320101 Oncologíaen_US
dc.subject320112 Radioterapiaen_US
dc.subject.otherBreasten_US
dc.subject.otherElderlyen_US
dc.subject.otherOligometastaticen_US
dc.subject.otherRadiotherapyen_US
dc.subject.otherStereotactic Ablative Radiotherapy (Sabr)en_US
dc.titleStereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patientsen_US
dc.typeinfo:eu-repo/semantics/reviewen_US
dc.typeArticleen_US
dc.identifier.doi10.21037/tcr.2019.08.29-
dc.identifier.scopus85078987882-
dc.contributor.authorscopusid57204723458-
dc.contributor.authorscopusid57208737651-
dc.contributor.authorscopusid8578988000-
dc.contributor.authorscopusid57190872784-
dc.contributor.authorscopusid57208739176-
dc.contributor.authorscopusid15723128900-
dc.contributor.authorscopusid7005353146-
dc.contributor.authorscopusid7003855087-
dc.contributor.authorscopusid7004374085-
dc.description.lastpageS206-
dc.description.firstpageS197-
dc.relation.volume9-
dc.investigacionCiencias de la Saluden_US
dc.type2Reseñaen_US
dc.utils.revisionen_US
dc.identifier.ulpgces
dc.description.sjr0,254
dc.description.jcr1,241
dc.description.sjrqQ4
dc.description.jcrqQ4
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.fullNameLloret Sáez-Bravo, Marta-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

1
actualizado el 24-mar-2024

Visitas

121
actualizado el 30-sep-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.